OUE Lippo Healthcare posts net loss of $4.01m in H2 22

For fiscal year 2022, its revenue grew to $119.8m YoY.

Healthcare group, OUE Lippo Healthcare, recorded a revenue of almost $120m in FY 2022, compared to $19.7m in FY 2021.

In its financial statement, its revenue increased to $77.194m in FY 2022 from $9m in FY 2021.

OUE Lippo Healthcare, however, reported a net loss of $4.01m in the second half of 2022.

For the full year that ended 31 December 2022, its profit after tax was at $32.5m in FY 2022 from $110.9m in the same period in 2021.

Higher revenue stemmed from its consolidation of first REIT and medical partners from 1 March last year and from 1 July last year and Wuxi Lippo Xi Nan hospital and the China pharmaceutical distribution business revenue growth.

Follow the link for more news on

OUE Lippo Healthcare

Financial Statements

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia